Manual De Novo Peptide MSMS Interpretation For Evaluating

  • Slides: 18
Download presentation
Manual De Novo Peptide MS/MS Interpretation For Evaluating Database Search Results Karl R. Clauser

Manual De Novo Peptide MS/MS Interpretation For Evaluating Database Search Results Karl R. Clauser Broad Institute of MIT and Harvard Bioinformatics for Protein Identification ASMS Fall Workshop Baltimore, MD November 5 -6, 2009 Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 1

Outline • AA properties • Fragmentation pathways and ion types • b/y pairs •

Outline • AA properties • Fragmentation pathways and ion types • b/y pairs • Fragment charge from mass defect • Non-mobile proton • Neutral loss ion types • Mass tolerance units and isobaric AA’s • Other Tutorials Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 2

AA Structures & Masses p. K: N-term 7. 5 6 p. K: 10 K

AA Structures & Masses p. K: N-term 7. 5 6 p. K: 10 K 128 H 137 N 114 12 R 156 D 115 S 87 Q 128 L 113 G 57 p. K: C-term 3. 5 p. K: 4. 0 4. 5 Y 163 P 97 I 113 A 71 T 101 E 129 M 131 V 99 F 147 C 103 (+57 IAA) Name Gly Ala Ser Val Thr Leu/Ile Asn Asp Lys/Gln Glu Met His Phe/Met-ox Arg Cys-IAA Tyr Trp AA G A S V T L/I N D K/Q E M H F/m R C Y W Mass 57 71 87 99 101 113 114 115 128 129 131 136 147 156 160 163 186 W 186 http: //ionsource. com/Card/clipart/aaclipart. htm Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 3

12/22/2021 4

12/22/2021 4

12/22/2021 5

12/22/2021 5

Charge-directed Fragmentation Scheme O H 2 N CH O C NH R 1 CH

Charge-directed Fragmentation Scheme O H 2 N CH O C NH R 1 CH C NH R 2 R 3 b ion formation O O R 2 R 3 Proton Mobility zpre > #Arg + #Lys + #His zpre < #Arg + #Lys + #His and > #Arg zpre < #Arg Karl Clauser Proteomics and Biomarker Discovery CH C OH R 4 y ion formation O + Neutral pumped away by vacuum system Mobile: Partially mobile: Non-mobile: H z. Hz+ O and/or b 3 H 2 N CH C NH CH C + R 1 CH O + C NH H O + NH CH H R 4 C OH y 1 + Neutral pumped away by vacuum system For peptides with non-mobile protons, fragmentation tends to proceed via charge-remote mechanisms. MS/MS spectra will be dominated by a few ions, typically: C-term side of D, E N-term side of P 12/22/2021 6

Sequence Specfic Fragment Ion Types a 3 O H 2 N CH C O

Sequence Specfic Fragment Ion Types a 3 O H 2 N CH C O NH R 1 CH C b 3 c 3 O NH R 2 CH C n. Hn+ O NH R 3 CH C OH R 4 x 1 y 1 z 1 Ion type restrictions residues delta a-NH 3 contains NH 3 residue RK NQ -17 b-NH 3, y-NH 3 contains NH 3 residue RK NQ -17 b-H 2 O, y-H 2 O contains H 2 O residue ST DE -18 st -98 b-H 3 PO 4, y-H 3 PO 4 contains H 3 PO 4 residue y++, b++ Karl Clauser Proteomics and Biomarker Discovery contains charged residues RHK 12/22/2021 7

Complementary Ions b/y pairs 128 99 99 128 E V Q L V|E/S|G|G|G L|V|K|P

Complementary Ions b/y pairs 128 99 99 128 E V Q L V|E/S|G|G|G L|V|K|P G GSLR Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 8

Dual Picket Fence 163 115 101 71 163 113 163 71 101 115 163

Dual Picket Fence 163 115 101 71 163 113 163 71 101 115 163 A E/D|T|A|L|Y|Y|C AK Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 9

Uniqueness of a Peptide Sequence Clauser, K. R. ; Baker, P. R. ; Burlingame,

Uniqueness of a Peptide Sequence Clauser, K. R. ; Baker, P. R. ; Burlingame, A. L. " Role of Accurate Mass Measurement ( +/- 10 ppm) in Protein Identification Strategies Employing MS or MS/MS and Database Searching", Anal. Chem. 1999, 71, 2871 -2882. Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 10

Diagnose Doubly Charged Fragment Ions I/A|D|A|H|L|D|R Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 11

Diagnose Doubly Charged Fragment Ions I/A|D|A|H|L|D|R Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 11

Dominant Cleavage Proline N-side 28 87 97 b 2 N F|P/S/P V D A

Dominant Cleavage Proline N-side 28 87 97 b 2 N F|P/S/P V D A A F R y 9 Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 12

Sparse Dominant Fragmentation 202 115 202 (K)I S R|P G D|S D|D|S R(S) Non-mobile

Sparse Dominant Fragmentation 202 115 202 (K)I S R|P G D|S D|D|S R(S) Non-mobile proton zpre < #Arg Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 13

Cry Babies (b-H 2 O & b pairs) P(m/z)-2 H 2 O P(m/z)-H 2

Cry Babies (b-H 2 O & b pairs) P(m/z)-2 H 2 O P(m/z)-H 2 O E/H/A|V/E|G/D|C D|F Q L L K Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 14

Stinkers (b-NH 3) & Pyroglutamic Acid (R)Q L/Q/L/A|Q/E/A|A QK(R) P(m/z)-NH 3 (R)q L/Q|L|A|Q|E|A|AQK(R) -17

Stinkers (b-NH 3) & Pyroglutamic Acid (R)Q L/Q/L/A|Q/E/A|A QK(R) P(m/z)-NH 3 (R)q L/Q|L|A|Q|E|A|AQK(R) -17 Da Q to q Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 15

Consequences of Inappropriate Tolerance Units (using Da tolerance when instrument errors are in ppm)

Consequences of Inappropriate Tolerance Units (using Da tolerance when instrument errors are in ppm) too loose too tight just right • Isobaric AA’s • I = L (C 6 H 11 N 1 O) = 113. 08406 • K ~ Q (C 6 H 12 N 2 O, C 5 H 8 N 2 O 2) 128. 09496 ~ 128. 05858 D =0. 03638 • F~m (C 9 H 9 N O, C 5 H 9 N O S) 147. 06841 ~ 147. 0354 D =0. 0330 • Isobaric AA combinations • GG=N (C 4 H 6 N 2 O 2 , C 4 H 6 N 2 O 2) 114. 04293 • GA=Q~K (C 5 H 8 N 2 O 2, C 6 H 12 N 2 O) 128. 09496 ~ 128. 05858 D =0. 03638 • DA~W~VS (C 7 H 10 N 2 O 4, C 11 H 11 N 2 O, C 8 H 14 N 2 O 3) 186. 06405 ~ 186. 07931 ~ 186. 10044 D =0. 01526 D =0. 02113 Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 16

Additional Resources Google: “de novo sequencing tutorial” Don Hunt and Jeff Shabanowitz - manual

Additional Resources Google: “de novo sequencing tutorial” Don Hunt and Jeff Shabanowitz - manual http: //www. ionsource. com/tutorial/De. Novo. TOC. htm Rich Johnson - manual http: //www. abrf. org/Research. Groups/Mass. Spectrometry/EPosters/ms 97 quiz/Sequencing. Tutorial. html PEAKS - automated http: //www. bioinformaticssolutions. com/products/peaks/support/tutorials/PEAKS_De_Novo. html Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 17

Acknowledgements Broad Institute MIT Steve Carr Terri Addona Jinyan Du Michael Yaffe Majbrit Hjerrld

Acknowledgements Broad Institute MIT Steve Carr Terri Addona Jinyan Du Michael Yaffe Majbrit Hjerrld Drew Lowery Karl Clauser Proteomics and Biomarker Discovery 12/22/2021 18